
The Top 25 IVD Companies: Revenue Performance, Products, Strategies, Market Activities
Description
IVD Market Top 25 Companies: Revenue Performance, Products, Competitive Activity
IVD Market Top 25 Companies presents advancements in in vitro diagnostics (IVD) by the Top 25 firms in the industry and provides an overview of the most recent trends and developments. Companies included are:
- Alere Inc.
- Arkray
- Beckman Coulter / Danaher
- Becton Dickinson
- Bio-Rad Laboratories
- bioMérieux
- Cepheid / Danaher
- Danaher Corp. (including Radiometer A/S)
- Grifols
- Hologic
- Illumina
- Instrumentation Laboratory / Werfen
- LabCorp, Laboratory Corporation of America
- Luminex
- Ortho Clinical Diagnostics
- PerkinElmer
- Qiagen N.V.
- Quest Diagnostics
- Quidel
- Roche Diagnostics (including Ventana Medical Systems)
- Philips
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
The report examines the major manufacturers in the IVD industry in terms of
- Recent Revenue History and Commentary
- Business Overview
- Revenue in Selected Test Segments
- Current and New Products
- Competitive Activity: M&A, Partnerships and Other Moves
IVD Market Top 25 Companies also presents highlights of IVD industry developments as demonstrated by a selection of small and niche firms in 2016 and the first half of 2017, which are preparing for the future with the development of next generation systems, informatics to help labs manage and retrieve test data, new infectious disease diagnostics, and gene-based oncology tests for targeted therapeutics.
This report on the advancements in in vitro diagnostics at the hands of the major companies provides an overview of the most recent trends and developments in the industry. It is not a comprehensive review of the diagnostics industry in general.
Clinical laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, miniaturization and microelectronics. Not five years ago it would have been almost inconceivable to see research technologies such as genome sequencing and mass spectroscopy play a pivotal role in improving lab medicine. Their influence is felt in personalized medicine, inherited diseases, pathogen detection, antibiotic resistance testing, blood banking and much more to come.
The top five majors continue to bring innovations to clinical diagnostics. However, of particular interest in the past year or so are the efforts made by companies such as Bio-Rad Laboratories, Illumina and Thermo Fisher Scientific. These and other companies are translating their portfolio of research-based molecular solution to clinical tools.
A review of the advancements reported by the major IVD companies included in this report shows innovations in CRISPR gene editing that is being adapted to the diagnosis of problematic diseases and the development of new therapeutics.
Table of Contents
225 Pages
- Exchange Rate Fluctuations, 2012-2016
- Market Trends
- Abbott Diagnostics
- Alere Inc.
- Arkray
- Beckman Coulter, Inc. / Danaher
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- bioMérieux Inc.
- Cepheid / Danaher
- Danaher Corporation
- Grifols
- Hologic, Inc.
- Illumina
- Instrumentation Laboratory (IL) / Werfen
- LabCorp, Laboratory Corporation of America
- Luminex Corporation
- Ortho Clinical Diagnostics (OCD)
- PerkinElmer, Inc. (PE)
- QIAGEN N.V.
- Quest Diagnostics
- Quidel Corporation
- Roche Diagnostics
- Royal Philips
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Selected New Products
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.